These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29072950)

  • 1. Biotin Interference in Clinical Immunoassays: A Cause for Concern.
    Holmes EW; Samarasinghe S; Emanuele MA; Meah F
    Arch Pathol Lab Med; 2017 Nov; 141(11):1459-1460. PubMed ID: 29072950
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of biotin interference in 21 Vitros 5600 immunoassays and risk mitigation for patient safety at a large academic medical center.
    Stieglitz HM; Korpi-Steiner N
    Clin Biochem; 2020 Jan; 75():53-61. PubMed ID: 31677994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotin interference in high-sensitivity cardiac troponin T testing: a real-world evaluation in acute cardiac care.
    Vroemen WHM; van Doorn WPTM; Kimenai DM; Wodzig WKWH; de Boer D; Bekers O; Meex SJR
    Cardiovasc Res; 2019 Dec; 115(14):1950-1951. PubMed ID: 31665256
    [No Abstract]   [Full Text] [Related]  

  • 4. Strategies for mitigating risk posed by biotin interference on clinical immunoassays.
    Gifford JL; de Koning L; Sadrzadeh SMH
    Clin Biochem; 2019 Mar; 65():61-63. PubMed ID: 30582902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discordant Analytical Results Caused by Biotin Interference on Diagnostic Immunoassays in a Pediatric Hospital.
    Ali M; Rajapakshe D; Cao L; Devaraj S
    Ann Clin Lab Sci; 2017 Sep; 47(5):638-640. PubMed ID: 29066495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotin interference in immunoassay: a review for the laboratory scientist.
    Avery G
    Ann Clin Biochem; 2019 Jul; 56(4):424-430. PubMed ID: 31023057
    [No Abstract]   [Full Text] [Related]  

  • 7.
    Dasgupta A; Khalil S; Paddock T; Wahed A
    Ann Clin Lab Sci; 2022 Jan; 52(1):161-163. PubMed ID: 35181630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best practices in mitigating the risk of biotin interference with laboratory testing.
    Bowen R; Benavides R; Colón-Franco JM; Katzman BM; Muthukumar A; Sadrzadeh H; Straseski J; Klause U; Tran N
    Clin Biochem; 2019 Dec; 74():1-11. PubMed ID: 31473202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual Presentation of Denys-Drash Syndrome in a Girl with Undisclosed Consumption of Biotin.
    Bizzarri C; Antonella Giannone G; Gervasoni J; Benedetti S; Albanese F; Dello Strologo L; Guzzo I; Mucciolo M; Diomedi Camassei F; Emma F; Cappa M; Porzio O
    J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):347-352. PubMed ID: 32840097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotin interference in routine laboratory tests: A bibliometric analysis.
    Waqas B; Lipner SR
    J Am Acad Dermatol; 2020 Dec; 83(6):1834-1838. PubMed ID: 32450100
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of the scope and magnitude of biotin interference in susceptible Roche Elecsys competitive and sandwich immunoassays.
    Trambas C; Lu Z; Yen T; Sikaris K
    Ann Clin Biochem; 2018 Mar; 55(2):205-215. PubMed ID: 28875734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive assessment of biotin interference in immunoassays.
    Li J; Wagar EA; Meng QH
    Clin Chim Acta; 2018 Dec; 487():293-298. PubMed ID: 30296442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic kidney failure and biotin: A combination inducing unusual results in thyroid and parathyroid investigations, report of 2 cases].
    Ranaivosoa MK; Ganel S; Agin A; Romain S; Parent X; Reix N
    Nephrol Ther; 2017 Dec; 13(7):553-558. PubMed ID: 29133077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotin-Induced Biochemical Graves Disease: A Teachable Moment.
    Sharma A; Baumann NA; Shah P
    JAMA Intern Med; 2017 Apr; 177(4):571-572. PubMed ID: 28192572
    [No Abstract]   [Full Text] [Related]  

  • 15. The biotin interference within interference suppressed immunoassays.
    Kabiri P; Weiskirchen R; van Helden J
    J Clin Lab Anal; 2021 Sep; 35(9):e23940. PubMed ID: 34346119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotin interference: Underrecognized patient safety risk in laboratory testing.
    Gifford JL; Sadrzadeh SMH; Naugler C
    Can Fam Physician; 2018 May; 64(5):370. PubMed ID: 29760259
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotin: an emerging analytical interference.
    Piketty ML; Souberbielle JC
    Ann Biol Clin (Paris); 2017 Aug; 75(4):366-368. PubMed ID: 28751281
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of detectable biotin in The Netherlands in relation to risk on immunoassay interference.
    IJpelaar A; Beijers A; van Daal H; van den Ouweland JMW
    Clin Biochem; 2020 Sep; 83():78-80. PubMed ID: 32473152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of biotin using streptavidin-coated microparticles: a validated solution to the problem of biotin interference in streptavidin-biotin immunoassays.
    Trambas C; Lu Z; Yen T; Sikaris K
    Ann Clin Biochem; 2018 Mar; 55(2):216-226. PubMed ID: 28406314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotin immunoassay interference: A UK-based prevalence study.
    Sanders A; Gama R; Ashby H; Mohammed P
    Ann Clin Biochem; 2021 Jan; 58(1):66-69. PubMed ID: 32936669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.